Stocktoria
Design Therapeutics, Inc. DSGN
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-03-26
Design Therapeutics, Inc. statistics & valuation
Market cap$833.8M
P / B3.9×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -30.9% | -19.7% | -23.1% | -18.6% | -9.1% |
| Return on equity | -32.8% | -20.5% | -24.1% | -19.3% | -9.3% |
| Current ratio | 17.14 | 29.31 | 29.58 | 31.10 | 72.96 |
Source: SEC EDGAR filings · CIK 0001807120 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.